Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human PRKCH Stable Cell Line

    [CAT#: S01YF-1023-PY67]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1222-KX447 Magic™ Human PKCη(PRKCH) in Vitro Assay Human Kinase Assay

    Product Information

    Target Family
    Kinases/Enzyme
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;Human primary glioma cells
    Target Classification
    Kinase Cell Lines
    Target Research Area
    CNS Research
    Related Diseases
    Stroke, Ischemic; Glioblastoma
    Gene ID
    Human:5583
    UniProt ID
    Human:P24723

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    PRKCH, also known as protein kinase C eta, has various applications in different fields. In the context of autism spectrum disorders (ASD), PRKCH is one of the risk genes for neurodevelopmental disorders and intellectual disabilities. DNA methylation profiling in both brain and blood tissues revealed that PRKCH is differentially methylated in these tissues, suggesting its involvement in altered gene regulation in the pathogenesis of ASD. In the field of dental research, mutations in PRKCH have been found to affect the splicing of amelogenin exon4, leading to the formation of a microRNA (miR-exon4) that plays a role in enamel and bone formation. PRKCH has also been implicated in cholesterol synthesis, where it is regulated by circRNAs and miRNAs. In glioma, PRKCH overexpression promotes tumorigenesis and influences glioma stem cell properties, making it a potential therapeutic target for gliomas. Additionally, PRKCH, along with other proteins such as PALLD, AKAP12, PDK4, and CHIT1, has been investigated for its role in the diagnosis and prognosis of neonatal sepsis. Overall, PRKCH has diverse applications in the fields of neurodevelopmental disorders, dental research, cholesterol synthesis, cancer, and neonatal sepsis.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human PRKCH Stable Cell Line (S01YF-1023-PY67). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Casey Miller (Verified Customer)

    What is the role of PRKCH in regulating the expression of transcription factor Runx2? Dec 02 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    PRKCH expression negatively correlates with miR-exon4-mediated Runx2 regulation, impacting bone development. Dec 02 2020

    chat Alex Davis (Verified Customer)

    How does PRKCH expression relate to the prognosis of neonatal sepsis? May 22 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Elevated levels of PRKCH in serum are associated with neonatal sepsis, suggesting its potential as a biomarker for diagnosis and prognosis. May 22 2020

    Published Data

    Fig.1 An increase in glioma cell growth is facilitated by the overexpression of PRKCH.

    To assess the promotion of glioma cell growth by PRKCH, an in vitro model of PRKCH knockdown and overexpression in glioma cells was created. In the KD group, cell viability was markedly reduced compared to the NC group, while in the OE group, cell viability was substantially elevated in comparison to the NC group.

    Ref: Pang, Fangning, et al. "Overexpression of PRKCH promotes tumorigenesis in patients with glioma and influences glioma stem cell properties." Pathology-Research and Practice 240 (2022): 154236.

    Pubmed: 36434855

    DOI: 10.1016/j.prp.2022.154236

    Research Highlights

    D Alberca, Carolina. et al. "Hippocampal and peripheral blood DNA methylation signatures correlate at the gene and pathway level in a mouse model of autism." Human molecular genetics, 2023.
    Autism spectrum disorders (ASD) are complex disorders caused by a combination of genetic and environmental factors. Recent studies have identified differential DNA methylation in peripheral tissues, such as the placenta, paternal sperm, buccal epithelium, and blood. However, there is a lack of comparison between DNA methylation levels in these peripheral tissues and brain tissue from the same individual. To address this, a study was conducted comparing whole genome methylation profiles in both brain and blood tissues from mice. This revealed 66 differentially methylated regions (DMRs) shared between the two tissues, many of which are associated with genes linked to neurodevelopmental disorders and intellectual disabilities. Analysis of gene ontological pathways showed that a significant number of terms were common between brain and blood tissues, with a large proportion related to brain/neuronal development. Additionally, seven DMR-associated genes contained methyl-sensitive transcription factor sequence motifs within the DMRs of both tissues, further supporting the role of DNA methylation in regulating gene expression in ASD. These findings suggest that peripheral blood may serve as a surrogate tissue for studying brain-related disorders and further support the contribution of DNA methylation in the development of ASD.
    D Alberca, Carolina. et al. "Hippocampal and peripheral blood DNA methylation signatures correlate at the gene and pathway level in a mouse model of autism." Human molecular genetics, 2023.
    Pubmed: 37658766   DOI: 10.1093/hmg/ddad137

    Shemirani, R. et al. "Mutations Causing X-Linked Amelogenesis Imperfecta Alter miRNA Formation from Amelogenin Exon4." Journal of dental research, 2023.
    Amelogenin plays a crucial role in tooth enamel formation, and mutations on X-chromosomal amelogenin cause X-linked amelogenesis imperfecta (AI). Amelogenin pre-messenger RNA (mRNA) is highly alternatively spliced, and during alternative splicing, exon4 is mostly skipped, resulting in the formation of a microRNA (miR-exon4) that is thought to play a role in enamel and bone formation. In an effort to better understand the regulation of amelogenin splicing, a study was conducted to examine the effects of known mutations in exon4 and exon5 on miR-exon4 production. Results showed that specific mutations, including c.120T>C, c.152C>T, c.155C>G, and c.155delC, significantly influenced the splicing of exon4 and subsequent miR-exon4 formation. In addition, the study identified the potential involvement of Ser/Arg-rich RNA splicing factors (SRSFs) 2 and 5 in regulating the splicing of exon4 and exon5, respectively. Further experiments with an amelogenin minigene transfected into HEK-293 cells demonstrated that mutations in each exon affected the binding of the corresponding SRSF. In LS8 ameloblastic cells, transfection of the amelogenin minigene led to a decrease in the expression of known miR-exon4 targets, miR-5p. Overall, these findings shed light on the important role of alternative splicing and its regulatory factors in producing functional variants of amelogenin proteins.
    Shemirani, R. et al. "Mutations Causing X-Linked Amelogenesis Imperfecta Alter miRNA Formation from Amelogenin Exon4." Journal of dental research, 2023.
    Pubmed: 37563801   DOI: 10.1177/00220345231180572

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare